Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-05-01
著者
-
OKITA Kiwamu
Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine
-
Okita Kiwamu
下関厚生病院(社保)
-
Okita Kiwamu
京都府立医科大学 消化器内科学
-
SAKAIDA Isao
Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine
-
Ohkawa Kazuyoshi
大阪大学
-
Ogata Kei
久留米大学 医学部第2内科消化器内科部門
-
Ogata Kei
The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive
-
Uchida K
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Uchida Koichi
Department Of Neurosurgery Keio University Medical School
-
Sakaida I
下関厚生病院(社保)
-
Sakaida Isao
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Sakaida Isao
Department Of Gastroenterology & Hepatology Yamaguchi University School Of Medicine
-
Uchida Koichi
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Uchida Koichi
Department Of Molecular Science And Applied Medicine (gastroenterology And Hepatology) Yamaguchi Uni
-
Uchida Koichi
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Yamaguchi University
-
Okita Kiwamu
Department Of Gastroenterology And Hepatology Yamaguchi University Graduate School Of Medicine
-
Okita K
Yamaguchi Univ. Yamaguchi Jpn
-
Omori Kaoru
Department Of Molecular Science & Applied Medicine (gastroenterology & Hepatology) Yamaguchi
-
Okita Kiwamu
First Department Of Internal Medical Yamaguchi University School Of Medicine
-
AKAZAWA Akiko
Department of Gastroenterology and Hepatology, Yamaguchi University, School of Medicine
-
HIGAKI Shingo
Department of Gastroenterology and Hepatology, Yamaguchi University, School of Medicine
-
KUBO Yoshitsugu
Department of Gastroenterology and Hepatology, Yamaguchi University, School of Medicine
-
Okita Kiwamu
Department Of First Internal Medicine Yamaguchi University School Of Medicine
-
Higaki Shingo
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Akazawa Akiko
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Kubo Yoshitsugu
Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine
-
Okita Kiwamu
Department Of Molecular Science & Applied Medicine (gastroenterology & Hepatology) Yamaguchi
-
Sakaida Isao
Department Of Gastroenterology & Hepatology School Of Medicine Yamaguchi University
-
Takami Taro
Division Of Laboratory Yamaguchi University Hospital
関連論文
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
- Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis
- Prolyl 4-hydroxylase inhibitor is more effective for the inhibition of proliferation than for inhibition of collagen synthesis of rat hepatic stellate cells
- HBV-related fulminant hepatic failure : successful intensive medical therapy in a candidate for liver transplantation
- Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity
- Interferon γ- but not α-treatment prevents fibrosis by inhibiting procollagen and tissue inhibitor of metalloproteinase-1 gene expression in pig serum-induced rat liver fibrosis in vivo
- Fulminant hepatitis complicated by small intestine infection and massive hemorrhage
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
- Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
- A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
- Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
- Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species
- In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C : correlation with hepatic steatosis
- Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells
- Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients : a comparison of immunohistochemical method vs. competitive polymerase chain reaction assay
- Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan
- A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma
- Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
- Detection of hepatitis B virus DNA in liver by polymerase chain reaction for the diagnosis of fulminant hepatitis B
- Therapeutic effect of secretin in patients with jaundice; Double-blind placebo-controlled multicentric trial
- D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson's disease : 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson's disease
- Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma
- Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy
- Arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and isovorin for patients with advanced hepatocellular carcinoma, pilot study : Is a high dose of the biochemical modulator effective?
- Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
- Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration
- Evaluation of the Reliability of Chromosomal Imbalances Detected by Combined Use of Universal DNA Amplification and Comparative Genomic Hybridization
- Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells
- Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat
- Effects of the elevation of serum bile acids on gastric mucosal damage
- α-Fetnprotein Containing Cells in Early Stages during Hepatocarcinogensis in Rats Fed 2－Acetylaminofluorene
- Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
- Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
- Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma : comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images
- Effects of a late evening snack combined with α-glucosidase inhibitor on liver cirrhosis
- Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen α2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-β
- Th1 down-regulation at the single-lymphocyte level in HCV-related liver cirrhosis and the effect of TGF-β on Th1 response : possible implications for the development of hepatoma
- Calcium Concentration and Artificial Precipitates in Human Pancreatic Juice
- A Case of Safe Endoscopic Removal of a Gastric Bezoar
- Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer
- Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis
- Polymorphisms of the IL-1β and IL-1β-inducible genes in ulcerative colitis
- Endoscopic ultrasonography for diagnosis of submucosal invasion in early gastric cancer
- Saikosaponin A-induced cell death of a human hepatoma cell line (HuH-7) : The significance of the 'sub-G_1 peak' in a DNA histogram
- Induction to Granulocytic Differentiation of Human Promyelocytic Leukemia Cells （HL－6０） by Polyprenoic Acid （E5166）
- High MDM2 mRNA expression in hepatoblastoma cell-lines
- Effects on liver functions of gastric variceal therapy by endoscopic ligation using a detachable snare and sclerotherapy with O-ring ligation
- Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase
- Ulcerative Colitis complicated by a Leaked Colojejunal Fistula: Report of a Case
- Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis
- Treatment of Hepatocellular Carcinoma by Inter-arterial Infusion with Mitomycin C
- Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the difference between genotypes III/2a and IV/2b
- Cytochrome c is a possible new marker for fulminant hepatitis in humans
- Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
- Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma : Is the addition of subcutaneous interferon-α-2b beneficial?
- Screening of hepatocellular cancer : Japanese strategy
- Development of cell therapy using autologous bone marrow cells for liver cirrhosis
- Lesson from the GFP/CCl4 model - Translational Research Project : the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis
- Rupture of peritoneal metastatic tumor that developed due to needle-tract implantation of hepatocellular carcinoma
- The effect of a late evening snack in patients with liver cirrhosis
- Late evening snack and the change of blood glucose level in patients with liver cirrhosis
- An In Vivo Model for Monitoring Trans-Differentiation of Bone Marrow Cells into Functional Hepatocytes
- Novel Findings for the Development of Drug Therapy for Various Liver Diseases:Current State and Future Prospects for Our Liver Regeneration Therapy Using Autologous Bone Marrow Cells for Decompensated Liver Cirrhosis Patients
- EFFECT OF MAPKS ACTIVITY ON MMP-2/TIMPS EXPRESSION IN HSC
- FIBROSIS ACCELERATES HEPATOCARCINOGENESIS
- The role of oxidative stress in NASH and fatty liver model
- Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C : a Japanese trial
- Expression of Sialylparagloboside in a Case of Liposarcoma: Aberrant Glycosylation in Tumors Arising in Adipose Tissues
- Afterword
- Afterword
- A new cell therapy using bone marrow cells to repair damaged liver
- Evaluation of power Doppler imaging in the management of small liver cancer
- Percutaneous hot water injection and microwave coagulation therapy for small hepatocellular carcinoma
- Changes of depolymerized and polymerized tubulin proteins in the liver after taurocholic acid administration with or without colchicine pretreatment and cholestasis due to cytochalasin B and bile duct ligation in rats
- Chemotaxis and motility of Helicobacter pylori in a viscous environment
- Protection by glycine against chemical ischemia produced by cyanide in cultured hepatocytes
- The effect of E3330 on active oxygen generation by isolated hepatic macrophages in rats
- Percutaneous hot water injection therapy (PHoT) for treatment of hepatocellular carcinoma: a comparision with percutaneous ethanol injection therapy (PEIT)
- Immunohistochemical study study of Fas antigen in liver of Patients with chronic hepatitis and autoimmune liver disease
- A case of Primary Biliary Cirrhosis with Benefucial Effect of Secrerin in the Treatment of Jaundice - with a Study of Secretin Induced Choloresis in Man-
- A Case Report of Seuretin Therapy for Primary Sclerosing Cholangitis
- Hepatocellular carcinoma with Hemobilia and Obstructive Jaundice
- Hepatitis B Virus Carrier Status Linked to Autoimmune Hepatitis
- "Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C
- Molecular Pathogenesis of Viral Hepatitis
- Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
- Cell Death Induced by Baicalein in Human Hepatocellular Carcinoma Cell Lines
- GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
- Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
- Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients
- Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy